Access to Technical Information Sample Clauses

Access to Technical Information. The Company made available to the respective authors thereof prior to the issuance of the Technical Reports, for the purpose of preparing the Technical Reports, as applicable, all information requested, and to the knowledge of the Company, no such information contained any material misrepresentation as at the relevant time the relevant information was made available; the Company does not have any knowledge of a material adverse change in any production, cost, price, reserves or other relevant information provided since the dates that such information was so provided.
View SourceView Similar (5)
Access to Technical Information. Subject to the provisions of Section 6 and Section 11.4 of this Agreement and to applicable confidentiality restrictions, the Partnership shall grant to each Partner and its Controlled Affiliates access to Technical Information of the Partnership ("Partnership Technical Information"). Such access shall be granted at such reasonable times and locations and on such other reasonable terms as the Managing Partner may approve, subject to Section 8.2(a). Subject to Section 6 and, in the case of rights to use Technical Information that have been licensed to the Partnership, to the terms and conditions contained in the related license to the Partnership, the Partnership shall grant to any such Partner or its Controlled Affiliate a license to use any Partnership Technical Information to which it is granted access pursuant to this Section 8.1(e) (and to make copies thereof at such Partner's expense), which license shall provide for royalties and fees and other terms and conditions that are generally prevailing with respect to comparable transactions involving unrelated third parties and are at least as favorable to such Partner or its Controlled Affiliate as those generally prevailing with respect to comparable licenses (if any) granted to non-Affiliates of Partners. The rights of access granted pursuant to this Section 8.1(e) shall be subject to the pre-existing rights of any third party to such Partnership Technical Information.
View SourceView Similar (5)
Access to Technical Information. The Technical Information specifically identified in Exhibit B was selected in Salk’s sole discretion for Licensee to use solely for the purpose permitted in Section 2.1.
View SourceView Similar (2)
Access to Technical Information. (i) In the event Supplier cannot provide a part in a timely manner to support maintenance or operation of a Contract Aircraft, then, at Customer’s request, Supplier shall provide Customer or Customer’s agent for part design (“Customer Part Designer”) all information (including drawings and manuals) necessary to permit Customer or Customer Part Designer to manufacture against a signed Approval to Manufacture (ATM) for the purposes of maintenance of a Contract Aircraft any parts designed by Supplier and provided as part of the Services for use on a Contract Aircraft. (ii) Supplier will provide all installation, assembly and detailed drawings related to the Conversion, which may be required for maintenance of a Contract Aircraft upon written request in support of (i) above.
View SourceView Similar (2)
Access to Technical Information. To facilitate the necessary system development by the User, Nord Pool may, on request, make available to the User certain technical information relating to a specific API (the “Technical Information”). The Technical Information is provided on an "as is" basis and without any warranty (express or implied). Nord Pool disclaims all warranties including any implied warranty of merchantability and/or fitness for a particular purpose. Each User that accesses the Technical Information for an API shall be bound by the terms of the API User Agreement from the moment such information is accessed.
View SourceView Similar (2)
Access to Technical Information. Upon request of a Party, the other Party will respond or permit the first Party to respond to any insurers in relation to all specific and reasonable questions relating to design, test, quality control, launch and orbital information. In addition, in the event a Party notifies or is notified by the other Party of an occurrence which may be expected to result in a Partial Loss or Constructive Total Loss under this Article 9.2, such other Party will permit and assist the first Party to: (i) conduct review sessions with a competent representative selected by the insurers to discuss any continued issue relating to such occurrence, including information conveyed to either Party; and (ii) use its best efforts to secure the insurers' access to all information used in or resulting from any investigation or review of the cause or effects of such occurrence; and (iii) make available for inspection and copying all information necessary to establish the scope of such occurrence and verifying the accounting methods employed to compute any refund payment obligated thereby.
View Source
Access to Technical Information. In addition to the manufacturing support described in Section 8.1 and in accordance with the License granted hereby, upon reasonable notice to Licensor, Licensor shall use all reasonable efforts to provide to Licensee Technical Information not part of Initial Transfer Materials for the purpose of enabling Licensee to obtain Licensee FDA Licensure, to manufacture the Product and the Frozen Formulation for sale in the Territory, and to improve the Product, for a period of two years after initial FDA licensure of the Product, and thereafter for the purposes of defending product liability and regulatory claims. Such access shall include consultation on reasonable notice with Licensor's employees knowledgeable about the Technical Information. Licensor shall only be obliged to answer Licensee's inquiries to the extent it is reasonably able to do so, and Licensor shall have no responsibility for any actions of Licensee based on such answers. Licensor shall not furnish, nor shall Licensee be deemed to have accepted, any information not requested by Licensee related to the Technical Information.
View Source

Related to Access to Technical Information

  • Technical Information The Employer agrees to provide to the Union such information that is available relating to employees in the bargaining unit, as may be required by the Union for collective bargaining purposes.

  • Proprietary Materials Each of the Parties shall own its own intellectual property including without limitation all trade secrets, know-how, proprietary data, documents, and written materials in any format. Any materials created exclusively by IPS for the School shall be owned by IPS, and any materials created exclusively by Operator for the School shall be Operator’s proprietary material. The Parties acknowledge and agree that neither has any intellectual property interest or claims in the other Party’s proprietary materials. Notwithstanding the foregoing, materials and work product jointly created by the Parties shall be jointly owned by the Parties and may be used by the individual Party as may be agreed upon by both Parties from time to time.

  • Medical Information Throughout the Pupil's time as a member of the School, the School Medical Officer shall have the right to disclose confidential information about the Pupil if it is considered to be in the Pupil's own interests or necessary for the protection of other members of the School community. Such information will be given and received on a confidential, need-to-know basis.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Licensed Technology (a) LICENSOR is not aware of any interference, infringement, misappropriation, or other conflict with any intellectual property rights of third parties, and LICENSOR has never received any charge, complaint, claim, demand, or notice alleging any such interference, infringement, misappropriation, or violation (including any claim that LICENSOR must license or refrain from using any intellectual property rights of any third party). To the knowledge of LICENSOR, no third party has interfered with, infringed upon, misappropriated, or otherwise come into conflict with any of the LICENSED TECHNOLOGY. (b) Exhibit A identifies each patent or registration which has been issued to LICENSOR with respect to any of the LICENSED TECHNOLOGY and identifies each pending patent application or application for registration which LICENSOR has made with respect to any of the LICENSED TECHNOLOGY. LICENSEE acknowledges that LICENSOR has previously made available to LICENSEE correct and complete copies of all such patents, registrations and applications (as amended to-date) in LICENSOR’s possession and has made available to LICENSEE correct and complete copies of all other written documentation in LICENSOR’s possession evidencing ownership and prosecution (if applicable) of each such item. (c) Exhibit A identifies each item of LICENSED TECHNOLOGY that is assigned to LICENSOR or that LICENSOR uses pursuant to license, sublicense, agreement, or permission. LICENSOR has made available to LICENSEE correct and complete copies of all such licenses, sublicenses, agreements, patent prosecution files and permissions (as amended to-date) in LICENSOR’s possession. With respect to each item of LICENSED TECHNOLOGY required to be identified in Exhibit A and to the knowledge of LICENSOR: (i) the license, sublicense, agreement, or permission covering the item is legal, valid, binding, enforceable, and in full force and effect; (ii) the license, sublicense, agreement, or permission will continue to be legal, valid, binding, enforceable, and in full force and effect on identical terms following the consummation of the transactions contemplated hereby; (iii) no Party to the license, sublicense, agreement, or permission is in breach or default, and no event has occurred which with notice or lapse of time would constitute a breach or default or permit termination, modification, or acceleration thereunder; (iv) no party to the license, sublicense, agreement, or permission has repudiated any provision thereof; (v) the underlying item of LICENSED TECHNOLOGY is not subject to any outstanding lien or encumbrance, injunction, judgment, order, decree, ruling, or charge; (vi) no action, suit, proceeding, hearing, investigation, charge, complaint, claim, or demand is pending or is threatened which challenges the legality, validity, or enforceability of the underlying item of LICENSED TECHNOLOGY; and (vii) except as provided in Exhibit A, LICENSOR has not granted any license or similar right to the LICENSED TECHNOLOGY within the GENERAL FIELD or PARTHENOGENESIS FIELD.